» Articles » PMID: 18284406

Recovery of Erectile Function After Nerve-sparing Radical Prostatectomy: Improvement with Nightly Low-dose Sildenafil

Overview
Journal BJU Int
Specialty Urology
Date 2008 Feb 21
PMID 18284406
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate the effect of low-dose sildenafil for rehabilitating erectile function after nerve-sparing radical prostatectomy (NSRP), as the delay to recovery of erectile function after NSRP remains under debate.

Patients And Methods: Forty-three sexually active patients had a NSRP; at 7-14 days after surgery they had a Rigiscan (Dacomed Corporation, Minneapolis, MN, USA) measurement of nocturnal penile tumescence and rigidity (NPTR). To support the recovery of spontaneous erectile function, 23 patients with preserved nocturnal erections received sildenafil 25 mg/day at night. A control group of 18 patients were then followed but had no phosphodiesterase-5 inhibitors. The International Index of Erectile Function (IIEF)-5 questionnaire was completed 6, 12, 24, 36 and 52 weeks after NSRP.

Results: Of the 43 patients, 41 (95%) had one to five erections during the first night after catheter removal. In the group using daily sildenafil the mean IIEF-5 score decreased from 20.8 before NSRP to 3.6, 3.8, 5.9, 9.6 and 14.1 at 6, 12, 24, 36 and 52 weeks after NSRP, respectively. In the control group the respective scores were 21.2, decreasing to 2.4, 3.8, 5.3, 6.4 and 9.3. There was a significant difference in IIEF-5 score and time to recovery of erectile function between the groups (P < 0.001), with potency rates of 86% vs 66%.

Conclusion: The measurement of NPTR after NSRP showed erectile function even the 'first' night after catheter removal. In cases of early penile erection, daily low-dose sildenafil leads to a significant improvement in the recovery of erectile function.

Citing Articles

Post-Radical Prostatectomy Erectile Dysfunction Assessed Using the IIEF-5 Questionnaire - A Systematic Literature Review.

Jurys T, Burzynski B, Potyka A, Paradysz A Int J Sex Health. 2024; 34(1):55-64.

PMID: 38595677 PMC: 10903601. DOI: 10.1080/19317611.2021.1936333.


Restoring Quality of Life: A Comprehensive Review of Penile Rehabilitation Techniques Following Prostate Surgery.

Thakur P, Gharde P, Prasad R, Wanjari M, Sharma R Cureus. 2023; 15(4):e38186.

PMID: 37261151 PMC: 10226834. DOI: 10.7759/cureus.38186.


Riluzole, a neuroprotective agent, preserves erectile function following bilateral cavernous nerve injury in male rats.

Barut E, Engin S, Kaya Yasar Y, Sezen S Int J Impot Res. 2023; 36(3):275-282.

PMID: 36788353 DOI: 10.1038/s41443-023-00680-x.


Comparison of the efficacy of the early LI-SWT plus daily tadalafil with daily tadalafil only as penile rehabilitation for postprostatectomy erectile dysfunction.

Jang S, Lee E, Chun S, Ha Y, Choi S, Lee J Int J Impot Res. 2022; 35(5):447-453.

PMID: 35347300 PMC: 10335924. DOI: 10.1038/s41443-022-00560-w.


Efficacy of phosphodiesterase type 5 inhibitors in patients with erectile dysfunction after nerve-sparing radical prostatectomy: a systematic review and meta-analysis.

Goh H, Sung J, Lee K, Jo J, Kim K Transl Androl Urol. 2022; 11(2):124-138.

PMID: 35280664 PMC: 8899138. DOI: 10.21037/tau-21-881.